|
HECTD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.725800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.765400E-01 |
| Normal-vs-Stage2 |
5.984000E-01 |
| Normal-vs-Stage3 |
1.815150E-01 |
| Normal-vs-Stage4 |
6.744800E-01 |
| Stage1-vs-Stage2 |
5.849000E-01 |
| Stage1-vs-Stage3 |
1.294150E-01 |
| Stage1-vs-Stage4 |
7.729600E-01 |
| Stage2-vs-Stage3 |
1.913640E-01 |
| Stage2-vs-Stage4 |
9.110800E-01 |
| Stage3-vs-Stage4 |
1.783040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.352000E-01 |
| Normal-vs-AfricanAmerican |
5.235800E-01 |
| Normal-vs-Asian |
7.747600E-01 |
| Caucasian-vs-AfricanAmerican |
3.245600E-01 |
| Caucasian-vs-Asian |
7.425400E-01 |
| AfricanAmerican-vs-Asian |
8.520800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.070400E-01 |
| Normal-vs-Female |
2.251400E-01 |
| Male-vs-Female |
7.785900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.440000E-01 |
| Normal-vs-Extreme_Weight |
9.084800E-01 |
| Normal-vs-Obese |
6.319800E-01 |
| Normal-vs-Extreme_Obese |
3.289800E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.299400E-01 |
| Normal_Weight-vs-Obese |
4.579600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.671600E-01 |
| Extreme_Weight-vs-Obese |
5.593800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.156400E-01 |
| Obese-vs-Extreme_Obese |
3.213800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.967950E-02 |
| Normal-vs-Age(41-60Yrs) |
1.848030E-01 |
| Normal-vs-Age(61-80Yrs) |
2.807000E-01 |
| Normal-vs-Age(81-100Yrs) |
6.405500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.983170E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.863600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.263800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.764200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.180300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.333400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.805170E-01 |
| Normal-VS-Type2 PRCC |
5.583700E-04 |
| Normal-VS-KIRP CIMP |
2.511000E-01 |
| Normal-VS-Unclassified PRCC |
5.680600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.0493000346965E-09 |
| Type1 PRCC-VS-KIRP CIMP |
8.053200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.923600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.829200E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.982930E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
6.249200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.373200E-01 |
| Normal-vs-N1 |
9.148200E-01 |
| Normal-vs-N2 |
5.643400E-01 |
| N0-vs-N1 |
4.541200E-01 |
| N0-vs-N2 |
9.437600E-01 |
| N1-vs-N2 |
6.346400E-01 |
|
|
